Document Detail

Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy.
MedLine Citation:
PMID:  15249636     Owner:  NLM     Status:  MEDLINE    
A 57-year-old man with chronic inflammatory demyelinating polyneuropathy associated with hepatitis C virus infection was treated successfully with the combination of peginterferon-alpha-2b and ribavirin. Viral eradication was confirmed during the 4th week of treatment and was followed 3 weeks later by neurologic improvement. The patient resumed normal activity 1 year after the therapy was completed.
P Corcia; D Barbereau; A M Guennoc; B de Toffol; Y Bacq
Related Documents :
17450036 - Hepatic steatosis has no impact on the outcome of treatment in patients with chronic he...
20417376 - Development of novel therapies for hepatitis c.
10447316 - Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients...
20001276 - Treatment of hepatitis c virus infection: updated swedish consensus recommendations.
23552416 - Novel recombinant hepatitis b virus vectors efficiently deliver protein and rna encodin...
21527986 - Genital hsv detection among hiv-1-infected pregnant women in labor.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Neurology     Volume:  63     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-07-13     Completed Date:  2004-12-21     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  179-80     Citation Subset:  AIM; IM    
Department of Neurology, CHRU Bretonneau, Tours, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / therapeutic use*
Drug Therapy, Combination
Hepatitis C, Chronic / complications,  diagnosis,  drug therapy*
Interferon Alfa-2b / therapeutic use*
Middle Aged
Polyethylene Glycols
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*,  etiology
Remission Induction
Ribavirin / therapeutic use*
Reg. No./Substance:
0/Antiviral Agents; 0/Polyethylene Glycols; 0/peginterferon alfa-2b; 36791-04-5/Ribavirin; 99210-65-8/Interferon Alfa-2b

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ventilatory support in facioscapulohumeral muscular dystrophy.
Next Document:  Cerebral lipiodol embolism during transcatheter arterial chemoembolization.